|Articles|January 1, 2002
- Pharmaceutical Technology-01-02-2002
- Volume 26
- Issue 1
Investigation of Out-of-Specification Results
The authors summarize the results of the September 2000 PhRMA workshop discussions about conducting out-of-specification investigations.
Advertisement
Articles in this issue
over 24 years ago
What Does Pharmacy Automation Mean for Packaging?over 24 years ago
Novel Acrylate Adhesives for Transdermal Drug Deliveryover 24 years ago
Optimal Tablet Press Operation: Machine versus Granulationover 24 years ago
Manufacturers Face Shifting Priorities in the New Yearover 24 years ago
Reaping the Benefits of E-Procurementover 24 years ago
Outsourcing OutlookAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Roche Gets Priority Review for Enspryng; Announces Sequencing Platform
2
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
3
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
4
Regulatory Developments Impacting Biologics
5
